Could a nerve zap cure sleep apnea? early trial recruits in latin america

NCT ID NCT06762873

Recruiting now Disease control Sponsor: Lunair Medical Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early-phase study will test whether a device that stimulates the phrenic nerve can help treat moderate-to-severe obstructive sleep apnea in 50 Latin American adults. Participants will undergo sleep studies and a procedure to map their airway collapse. The goal is to see if this neuromodulation therapy works differently in this population compared to previous US studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: phrenic nerve stimulation device
What this could lead to: If successful, this could point toward a new treatment option for obstructive sleep apnea in Latin American populations.
What could go wrong: This is a very early (Phase 1) study with only 50 participants, so results may not apply widely. The therapy may not work as well as hoped or could have unknown side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBSTRUCTIVE SLEEP APNEA

Contacts and locations

Locations

Sanatorio Americano
RECRUITING

Asunción, Paraguay

More trials for these conditions

Other studies related to the condition(s) this trial covers.